Leader Nicotine Polacrilex Interactions
There are 31 drugs known to interact with Leader Nicotine Polacrilex (nicotine), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 21 are moderate, and 10 are minor.
- View all 31 medications that may interact with Leader Nicotine Polacrilex
- View Leader Nicotine Polacrilex alcohol/food interactions (1)
- View Leader Nicotine Polacrilex disease interactions (8)
Most frequently checked interactions
View interaction reports for Leader Nicotine Polacrilex (nicotine) and the medicines listed below.
- acetaminophen
- albuterol
- amlodipine
- aspirin
- atorvastatin
- bupropion
- buspirone
- clonidine
- cyclobenzaprine
- duloxetine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluticasone nasal
- gabapentin
- hydrochlorothiazide
- hydroxyzine
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- melatonin
- metformin
- metoprolol
- naproxen
- omeprazole
- prednisone
- propranolol
- sertraline
- trazodone
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Leader Nicotine Polacrilex alcohol/food interactions
There is 1 alcohol/food interaction with Leader Nicotine Polacrilex (nicotine).
Leader Nicotine Polacrilex disease interactions
There are 8 disease interactions with Leader Nicotine Polacrilex (nicotine) which include:
More about Leader Nicotine Polacrilex (nicotine)
- Leader Nicotine Polacrilex consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: smoking cessation agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.